✦ LIBER ✦

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

✍ Scribed by Marta Santisteban; Jan C. Buckner; Joel M. Reid; Wenting Wu; Bernd W. Scheithauer; Matthew M. Ames; Sara J. Felten; Daniel A. Nikcevich; Martin Wiesenfeld; Kurt A. Jaeckle; Evanthia Galanis

Book ID: 106481147
Publisher: Springer US
Year: 2008
Tongue: English
Weight: 235 KB
Volume: 92
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-008-9749-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized multicenter Phase II trial of

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1

A north central cancer treatment group P

A north central cancer treatment group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

✍ Henry C. Pitot; James A. Knost; Michelle R. Mahoney; John Kugler; James E. Krook 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 3 views

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Use of KW-2189, a DNA Minor Groove-Bindi

Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial

✍ Steven R. Alberts; Vera J. Suman; Henry C. Pitot; John K. Camoriano; Joseph Rubi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 84 KB

A phase II trial of nab-paclitaxel (ABI-

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E1

✍ Lisa A. Kottschade; Vera J. Suman; Thomas Amatruda III; Robert R. McWilliams; Ba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor